Yuliang Li

11PUBLICATIONS
32CO-AUTHORS
Molecular targetsTraditional Chinese medicine and treatmentsMedical devicesCancer therapy (excl. chemotherapy and radiation therapy)Analytical spectrometry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 08, 2026
Synergistic effect of Pladienolide B and cisplatin: enhancing autophagy in hepatoma cells through the AMPK/mTOR/ULK1 pathway.

|Mar 02, 2026
Splice-switching of the oncogenic BCS1L isoform suppresses ovarian cancer progression by disrupting mitochondrial function.

Meining Xu, Zixiang Wang, Siyuan Yang

|Feb 10, 2025
Exploring the mechanism of SLXG for treating nonalcoholic fatty liver disease based on network pharmacology and molecular docking.

Yang Wang, Jiaxing Wang, Zitong Chen

|Nov 28, 2024
The Use of Modified 3D-Printed Models for Precise Fenestrations in Physician-Modified Endografts to Treat Aortic Dissections Involving Visceral Branches.

Yihong Jiang, Hongji Pu, Jiahao Lei

|Apr 16, 2024
Stereotactic ablative brachytherapy versus percutaneous microwave ablation as salvage treatments for lung oligometastasis from colorectal cancer.

Yuliang Li, Zitong Chen, Shuhui Tian

|Aug 10, 2023
Characterization of circSEC11A as a novel regulator of Iodine-125 radioactive seed-induced anticancer effects in hepatocellular carcinoma via targeting ZHX2/GADD34 axis.

Dong Li, Wujie Wang, Bin Liu

Pageof 2

Frequent Collaborators

2 joint publications

Dong Li

2 joint publications

Changjun Wang

2 joint publications

Zhaojian Liu

2 joint publications

Yongzheng Wang